Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2,-2B and SPANX-B, during mesenchymal-to-epithelial transition

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Yilmaz Ozcan, Sinem ^a   Sade, Asli ^b   Kucukkaraduman, Baris ^a   Kaygusuz, Yasemin ^a   Senses, Kerem Mert ^a   Banerjee, Sreeparna ^b   Gure, Ali Osmay ^a  

^a BILKENT UNIVERSITY   (Turkey)

^b MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; CLAUDIN 4; FIBRONECTIN; HETEROCHROMATIN PROTEIN 1; MEMBRANE PROTEIN; TEN ELEVEN TRANSLOCATION 2; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR EZH2; TRANSGELIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; DNA BINDING PROTEIN; EZH2 PROTEIN, HUMAN; HETEROCHROMATIN-SPECIFIC NONHISTONE CHROMOSOMAL PROTEIN HP-1; NONHISTONE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PAGE2 PROTEIN, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2; SPANXB1 PROTEIN, HUMAN; TET2 PROTEIN, HUMAN; TUMOR ANTIGEN;

ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PAGE2 GENE; PAGE2B GENE; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPANX B GENE; UPREGULATION; CELL TRANSDIFFERENTIATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSDIFFERENTIATION; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NUCLEAR PROTEINS; POLYCOMB REPRESSIVE COMPLEX 2; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS;

EID: 84907212861     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107905     Document Type: Article

References (42)

1. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immuno-logical Reviews 188: 22-32.
2. Caballero OL, Chen YT (2009) Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100: 2014-2021.
3. Hofmann O, Caballero OL, Stevenson BJ, Chen YT, Cohen T, et al. (2008) Genome-wide analysis of cancer/testis gene expression. Proceedings of the National Academy of Sciences of the United States of America 105: 20422-20427.
4. Loriot A, Reister S, Parvizi GK, Lysy PA, De Smet C (2009) DNA methylation-associated repression of cancer-germline genes in human embryonic and adult stem cells. Stem Cells 27: 822-824.
5. Mashino K, Sadanaga N, Tanaka F, Yamaguchi H, Nagashima H, et al. (2001) Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Br J Cancer 85: 713-720.
6. Gure AO, Chua R, Williamson B, Gonen M, Ferreira CA, et al. (2005) Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clinical Cancer Research 11: 8055-8062.
7. Woloszynska-Read A, Mhawech-Fauceglia P, Yu JH, Odunsi K, Karpf AR (2008) Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer. Clinical Cancer Research 14: 3283-3290.
8. Jungbluth AA, Busam KJ, Kolb D, Iversen K, Coplan K, et al. (2000) Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer 85: 460-465.
9. Jungbluth AA, Chen YT, Busam KJ, Coplan K, Kolb D, et al. (2002) CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues. Int J Cancer 99: 839-845.
10. Jungbluth AA, Stockert E, Chen YT, Kolb D, Iversen K, et al. (2000) Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer 83: 493-497.
11. Chen YT, Chiu RT, Lee P, Beneck D, Jin BQ, et al. (2011) Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma. Human Reproduction 26: 3232-3243.
12. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, et al. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659.
13. Hoek KS (2007) DNA microarray analyses of melanoma gene expression: a decade in the mines. Pigment Cell Res 20: 466-484.
14. Argast GM, Krueger JS, Thomson S, Sujka-Kwok I, Carey K, et al. (2011) Inducible expression of TGF beta, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model. Clinical & Experimental Metastasis 28: 593-614.
15. Astarci E, Sade A, Cimen I, Savas B, Banerjee S (2012) The NF-kappaB target genes ICAM-1 and VCAM-1 are differentially regulated during spontaneous differentiation of Caco-2 cells. FEBS J 279: 2966-2986.
16. Fleet JC, Wang L, Vitek O, Craig BA, Edenberg HJ (2003) Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation. Physiol Genomics 13: 57-68.
17. Loboda A, Nebozhyn MV, Watters JW, Buser CA, Shaw PM, et al. (2011) EMT is the dominant program in human colon cancer. BMC Medical Genomics 4.
18. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
19. Pinto M, Robineleon S, Appay MD, Kedinger M, Triadou N, et al. (1983) Enterocyte-Like Differentiation and Polarization of the Human-Colon Carcinoma Cell-Line Caco-2 in Culture. Biology of the Cell 47: 323-330.
20. Simon-Assmann P, Turck N, Sidhoum-Jenny M, Gradwohl G, Kedinger M (2007) In vitro models of intestinal epithelial cell differentiation. Cell Biology and Toxicology 23: 241-256.
21. Halbleib JM, Saaf AM, Brown PO, Nelson WJ (2007) Transcriptional modulation of genes encoding structural characteristics of differentiating Enterocytes during development of a polarized epithelium in vitro. Molecular Biology of the Cell 18: 4261-4278.
22. Saaf AM, Halbleib JM, Chen X, Yuen ST, Leung SY, et al. (2007) Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol Biol Cell 18: 4245-4260.
23. Fratta E, Coral S, Covre A, Parisi G, Colizzi F, et al. (2011) The biology of cancer testis antigens: putative function, regulation and therapeutic potential. Mol Oncol 5: 164-182.
24. Cannuyer J, Loriot A, Parvizi GK, De Smet C (2013) Epigenetic Hierarchy within the MAGEA1 Cancer-Germline Gene: Promoter DNA Methylation Dictates Local Histone Modifications. Plos One 8.
25. Wang ZQ, Zhang J, Zhang YN, Lim SH (2006) SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically. International Journal of Cancer 118: 1436-1444.
26. Wang ZQ, Zhang J, Zhang Y, Srivenugopal K, Lim SH (2006) SPAN-XB core promoter sequence is regulated in myeloma cells by specific CpG dinucleotides associated with MeCP2 protein. Blood 108: 628a-628a.
27. Iyer LM, Tahiliani M, Rao A, Aravind L (2009) Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 8: 1698-1710.
28. Loenarz C, Schofield CJ (2009) Oxygenase catalyzed 5-methylcytosine hydroxylation. Chem Biol 16: 580-583.
29. Wang Y, Zhang Y (2014) Regulation of TET Protein Stability by Calpains. Cell Rep 6: 278-284.
30. Jiang Y, Liu S, Chen X, Cao Y, Tao Y (2013) Genome-wide distribution of DNA methylation and DNA demethylation and related chromatin regulators in cancer. Biochim Biophys Acta 1835: 155-163.
31. Sun F, Chan E, Wu Z, Yang X, Marquez VE, et al. (2009) Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells. Mol Cancer Ther 8: 3191-3202.
32. Tsukada Y (2012) Hydroxylation mediates chromatin demethylation. J Biochem 151: 229-246.
33. Solary E, Bernard OA, Tefferi A, Fuks F, Vainchenker W (2014) The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 28: 485-496.
34. Blaschke K, Ebata KT, Karimi MM, Zepeda-Martinez JA, Goyal P, et al. (2013) Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500: 222-226.
35. Wen L, Li X, Yan L, Tan Y, Li R, et al. (2014) Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain. Genome Biol 15: R49.
36. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, et al. (2011) Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473: 398-402.
37. Song SJ, Poliseno L, Song MS, Ala U, Webster K, et al. (2013) MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 154: 311-324.
38. Hahn MA, Qiu R, Wu X, Li AX, Zhang H, et al. (2013) Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. Cell Rep 3: 291-300.
39. Gjerstorff MF, Harkness L, Kassem M, Frandsen U, Nielsen O, et al. (2008) Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiation. Hum Reprod 23: 2194-2201.
40. Yao D, Dai C, Peng S (2011) Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res 9: 1608-1620.
41. Isbilen M, Senses KM, Gure AO (2013) Predicting Chemotherapy Sensitivity Profiles for Breast Cancer Cell Lines with and Without Stem Cell-Like Features. Curr Signal Transduct Ther 8: 268-273.
42. Isbilen M, Gure AO (2014) Identifying effective molecularly targeted drugs for hematological cancers. Turkiye Klinikleri J Hematol-SpecialTopics 7: 1-7.